Oragenics - Investor Overview

Investor Overview

Market Capitalization (as of November 30, 2007)

Common shares authorized 100,000,000

Common shares issued and outstanding 28,000,000

Warrants issued and unexercised 2,375,000

Stock options granted and unexercised 1,295,000

Fully diluted 26,034,943

Exchanges

AMEX American Stock Exchange - ONI

Transfer Agent

Continental Stock Transfer & Trust Company, Inc.
17 Battery Place
New York, NY 10004
Phone 212-509-4000

Corporate Counsel

Shumaker, Loop & Kendrick, LLP
101 East Kennedy Blvd., Suite 2800
Tampa, FL 33672-0609
Phone 813-229-7600

Independent Accountants

Kirkland Russ Murphy & Tapp
13577 Feather Sound Drive, Suite 400
Clearwater, FL 33762-5539
Phone 727-572-1400

The documents contained in (or directly accessible from) this website include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about growth strategies, development of technologies, financing, operational trends, regulatory compliance and any other statements containing the words "believes", "expects", "anticipates", "plans", "estimates" and similar expressions. There are a number of important factors that could cause Oragenics' actual results to differ materially from those indicated by such forward-looking statements, including factors identified in the company's most recent Annual Report on Form 10-KSB and subsequent reports filed with the SEC. The company disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date such statement was first made.